Buscar resultados de ensayos clínicos
Ascites - 164 Studies Found
Estado | Estudiar |
Terminated |
Nombre del estudio: Trial of Sunitinib for Refractory Malignant Ascites Condición: Ascites Fecha: 2008-11-21 Intervenciones: Drug: Sunitinib Patients will be given Sunitinib 50 mg orally daily for four weeks, followed by a two we |
Completed |
Nombre del estudio: Safety and Performance of the Automated Fluid Shunt in Patients With Ascites and Diuretic Resistance Condición: Ascites Fecha: 2009-12-10 Intervenciones: Device: NovaShunt's Automated Fluid Shunt implantation The Automated Fluid Shunt (AFS) Device consists o |
Terminated |
Nombre del estudio: Sodium Restriction in the Management of Cirrhotic Ascites Condición: Ascites Fecha: 2007-10-22 Intervenciones:
|
Recruiting |
Nombre del estudio: To Study the Effect of Nonselective Beta Blockers in Advanced Stage Liver Disease With Ascites Condición: Ascites Fecha: 2015-12-05 Intervenciones:
|
Terminated |
Nombre del estudio: An Early Safety and Efficacy Study of Ascites Management: Standard Paracentesis or Early Intervention With Pleurx Catheters in Patients With Malignant Ascites Condición: Malignant Ascites Fecha: 2010-02-25 Intervenciones:
|
Recruiting |
Nombre del estudio: Palliative Care Outcomes in the Management of Malignant Ascites by Interventional Radiology Condición: Refractory Malignant Ascites Fecha: 2015-06-16 Intervenciones:
|
Withdrawn |
Nombre del estudio: A Study of Bevacizumab to Prevent Malignant Ascites Condición: Malignant Ascites Fecha: 2009-05-21 Intervenciones: Drug: Bevacizumab Bevacizumab is given as an IV infusion of 15 mg/kg every three weeks for 12 weeks. |
Active, not recruiting |
Nombre del estudio: Impact of Palliative Catheter Placement on the Quality of Life of Patients With Refractory Ascites Condición: Ascites Fecha: 2010-08-24 Intervenciones: Behavioral: McGill Quality of Life Questionnaire and the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire |
Recruiting |
Nombre del estudio: Symptomatic Ascites Drainage With a Patient-controlled Vascular Catheter. Condición: Malignant Ascites Fecha: 2016-03-20 Intervenciones:
|
Completed |
Nombre del estudio: Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites Condición: Malignant Ascites Fecha: 2006-05-15 Intervenciones: Drug: catumaxomab Catumaxomab is administered intraperitoneally via an indwelling catheter (or port) as |